Literature DB >> 20960295

Expression and immunological analysis of capsid protein precursor of swine vesicular disease virus HK/70.

Hong Tian1, Jing-yan Wu, You-jun Shang, Shuang-hui Ying, Hai-xue Zheng, Xiang-tao Liu.   

Abstract

VP1, a capsid protein of swine vesicular disease virus, was cloned from the SVDV HK/70 strain and inserted into retroviral vector pBABE puro, and expressed in PK15 cells by an retroviral expression system. The ability of the VP1 protein to induce an immune response was then evaluated in guinea pigs. Western blot and ELISA results indicated that the VP1 protein can be recognized by SVDV positive serum, Furthermore, anti-SVDV specific antibodies and lymphocyte proliferation were elicited and increased by VP1 protein after vaccination. These results encourage further work towards the development of a vaccine against SVDV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960295      PMCID: PMC8227878          DOI: 10.1007/s12250-010-3100-x

Source DB:  PubMed          Journal:  Virol Sin        ISSN: 1995-820X            Impact factor:   4.327


  17 in total

Review 1.  Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy.

Authors:  E Vigna; L Naldini
Journal:  J Gene Med       Date:  2000 Sep-Oct       Impact factor: 4.565

2.  Determination of infectious retrovirus concentration from colony-forming assay with quantitative analysis.

Authors:  Young Jik Kwon; Gene Hung; W French Anderson; Ching-An Peng; Hong Yu
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

3.  Molecular epidemiology of recent outbreaks of swine vesicular disease: two genetically and antigenically distinct variants in Europe, 1987-94.

Authors:  E Brocchi; G Zhang; N J Knowles; G Wilsden; J W McCauley; O Marquardt; V F Ohlinger; F De Simone
Journal:  Epidemiol Infect       Date:  1997-02       Impact factor: 2.451

4.  Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus.

Authors:  Belén Borrego; Elena Carra; Juan Antonio García-Ranea; Emiliana Brocchi
Journal:  J Gen Virol       Date:  2002-01       Impact factor: 3.891

5.  Induction of neutralizing antibodies by structural proteins VP1 and VP2 of swine vesicular disease virus.

Authors:  T Tsuda; T Tokui; T Onodera
Journal:  Nihon Juigaku Zasshi       Date:  1987-02

6.  Herd sensitivity in relation to test sensitivity in swine vesicular disease serological tests.

Authors:  A Dekker
Journal:  Rev Sci Tech       Date:  2005-12       Impact factor: 1.181

7.  A foot and mouth disease syndrome in pigs caused by an enterovirus.

Authors:  L Nardelli; E Lodetti; G L Gualandi; R Burrows; D Goodridge; F Brown; B Cartwright
Journal:  Nature       Date:  1968-09-21       Impact factor: 49.962

8.  Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus.

Authors:  Shi-Qi Sun; Xiang-Tao Liu; Hui-Chen Guo; Shuang-Hui Yin; You-Jun Shang; Xia Feng; Zai-Xin Liu; Qing-Ge Xie
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

9.  Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes.

Authors:  M Kozak
Journal:  Cell       Date:  1986-01-31       Impact factor: 41.582

10.  Infective viruses produced from full-length complementary DNA of swine vesicular disease viruses HK/70 strain.

Authors:  Haixue Zheng; Xiangtao Liu; Youjun Shang; Jinyan Wu; Xingwen Bai; Ye Jin; Shiqi Sun; Huichen Guo; Hong Tian; Xia Feng; Shuanghui Yin; Jianhong Guo; Guozheng Cong; Zaixin Liu; Huiyun Chang; Junwu Ma; Qingge Xie
Journal:  Chin Sci Bull       Date:  2006
View more
  1 in total

1.  Tumor Necrosis Factor (TNF) Receptor Expression Determines Keratinocyte Fate upon Stimulation with TNF-Like Weak Inducer of Apoptosis.

Authors:  Xuening Wang; Dan Cheng; Guanglei Hu; Lili Liang; Fei Tan; Tong Xiao; Shengxiang Xiao; Yumin Xia
Journal:  Mediators Inflamm       Date:  2019-12-05       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.